[HTML][HTML] Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non …

GK Rai, T Saluja, S Chaudhary, D Tamrakar… - The Lancet Infectious …, 2022 - thelancet.com
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

[HTML][HTML] Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non …

GK Rai, T Saluja, S Chaudhary, D Tamrakar… - The Lancet Infectious …, 2022 - Elsevier
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

[HTML][HTML] Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non …

GK Rai, T Saluja, S Chaudhary… - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority …

T Saluja, S Chaudhary, D Tamrakar… - The Lancet. Infectious …, 2021 - europepmc.org
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority …

G Kumar Rai, T Saluja, S Chaudhary, D Tamrakar… - 2021 - cabidigitallibrary.org
Background: Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …

Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority …

GK Rai, T Saluja, S Chaudhary… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Typhoid fever is an endemic disease in many low-income and middle-income
countries. The 2018 WHO position paper recommends that countries should consider …